Skip to content

Author

N. Di Donato

We have 5 of 148 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

#gene editing Case report Open access Nov 2026

Liver biopsy confirms precise and efficient correction of SERPINA1 after in vivo Base Editing in a Patient with Alpha-1 Antitrypsin Deficiency.

Sustained biologically active AAT levels support feasibility and potential of this approach for the treatment of AATD, and substantial and precise hepatic correction of the pathogenic SERPINA1 PI*ZZ variant is achieved.

S. Krooss, Tai-Hua Yang, Q. Yuan et al. · 0 citations
#edge computing Open access Oct 2026

Pleuroparenchymal fibroelastosis in a monogenic mitochondrial DNA depletion syndrome.

BACKGROUND Pleuroparenchymal fibroelastosis (PPFE) is a rare, most often idiopathic fibrotic lung disease with poor prognosis, mainly affecting adults. Biallelic pathogenic variants in the deoxyguanosine kinase gene (DGUOK) cause a mitochondrial DNA (mtDNA) depletion syndrome, predominantly affecting infants with sever...

S. von Hardenberg, Pia Maier, Leonard Christian et al. · 0 citations
Open access Sep 2026

Coordinated neural progenitor adaptations contribute to primate neocortical downscaling

Here, coordinated adaptations in NPC biology that bias neurodevelopmental trajectories toward neocortical downscaling are identified and multiple adaptations in apical and basal progenitors that converge on reduced progenitor capacity, alter early progenitor dynamics, and likely constrain neuronal output are uncovered.

Lidiia Tynianskaia, Cesar Mateo Bastidas-Betancourt, Esther Marie Grewe et al. · 0 citations
Open access Sep 2026

Beyond in silico prediction: multi-omics to identify a pathogenic deep intronic HNRNPK variant in Au-Kline syndrome.

This case report supports the relevance of facial analysis and comprehensive variant validation strategies, particularly for deep intronic variants with ambiguous in silico splicing predictions, particularly for deep intronic variants with ambiguous in silico splicing predictions.

Z. Kowalzyk, J. Porrmann, P. Au et al. · 0 citations
Open access Aug 2026

Generation of diseased and isogenic control human induced pluripotent stem cell lines MHHi043-A & MHHi043-B from a female Fabry disease patient carrying c.644A > G missense mutation.

Two human induced pluripotent stem cell lines from a female FD patient carrying a heterozygous c.644A > G missense mutation provide a valuable resource for studying FD mechanisms and developing therapeutic strategies.

Nick Heise, Carla Borisch, Christopher Jahn et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.